All Stories

  1. Rationale, principles and global health implications of establishing public health pharmacology as a distinct discipline
  2. Tumor Necrosis Factor-Alpha (TNF- α) and Antiviral Activities of Artemisia SPP. Extracts on SARS-COV2
  3. Expression and Purification of the Full Length and N-Terminal Truncated Variants of Insect CYP6Z2 in the Cytosol of Escherichia Coli for Potential 3D Experimental Studies
  4. Advancing Vaccinology Capacity: Education and Efforts in Vaccine Development and Manufacturing across Africa
  5. Advancing Vaccinology Capacity: Education and Efforts in Vaccine Development and Manufacturing across Africa
  6. Vaccination and vaccine-preventable diseases in Africa
  7. Confronting Vaccine Production, Efficacy, Safety, and Accessibility Challenges in Africa
  8. Malaria rapid diagnostic tests in community pharmacies in Rwanda: availability, knowledge of community pharmacists, advantages, and disadvantages of licensing their use
  9. Alternative Medicine in Health Care: Is the Time not Now to Standardize African Phytomedicine to Indigenize Health Care and Create Entrepreneurial Opportunities?
  10. Bypassing shortages of personal protective equipment in low-income settings using local production and open source tools
  11. PPEs From Nigerian Academia: Flattening The COVID-19 Curve With 3D Printing And Locally Sourced Intervention
  12. Use of mobile phones for patient self-reporting adverse drug reactions: A pilot study at a tertiary hospital in Rwanda
  13. Pharmacognosy: Importance and Drawbacks
  14. Analgesic Appraisal of Bidens pilosa (Asteraceae) Leaf Extracts Used in Management of Oral Lesion Pain in HIV/AIDS Patients in Rodents
  15. Addressing knowledge gaps in molecular, sero-surveillance and monitoring approaches on Zika epidemics and other arbovirus co-infections: A structured review
  16. Can free open access resources strengthen knowledge-based emerging public health priorities, policies and programs in Africa?
  17. Scaling up impact of malaria control programmes: a tale of events in Sub-Saharan Africa and People’s Republic of China
  18. Exposure to anti-malarial drugs and monitoring of adverse drug reactions using toll-free mobile phone calls in private retail sector in Sagamu, Nigeria: implications for pharmacovigilance
  19. Asexual and sexual stages of Plasmodium falciparum in Nigerian pregnant women attending antenatal booking clinic
  20. Clinical Profiles of Newborns with Malaria Parasitaemia in Sagamu
  21. Activities of Artesunate and Amodiaquine against Intestinal Helminth in Children with Plasmodium falciparum Malaria in Endemic Area
  22. Herpes simplex labialis in children with acute falciparum malaria
  23. Activities of artesunate and amodiaquine against intestinal helminth in children with Plasmodium falciparum malaria in endemic areas
  24. Activities of Artemether-Lumefantrine and Amodiaquine-Sulfalene-Pyrimethamine against Sexual-Stage Parasites in Falciparum Malaria in Children
  25. Effects of artesunate-cotrimoxazole and amodiaquine-artesunate against asexual and sexual stages of Plasmodium falciparum malaria in Nigerian children
  26. Comparative Study of Efficacy of Amodiaquine-Cotrimoxazole and Amodiaquine-Pyrimethamine Sulphadoxine in the Treatment of Malaria in Nigerian Children
  27. Enhancement of the antimalarial efficacy of amodiaquine by chlorpheniramine in vivo
  28. Activities of Amodiaquine, Artesunate, and Artesunate-Amodiaquine against Asexual- and Sexual-Stage Parasites in Falciparum Malaria in Children
  29. Effects of acute Plasmodium falciparum malaria on body weight in children in an endemic area
  30. Effects of pyrimethamine-sulphadoxine, chloroquine plus chlorpheniramine, and amodiaquine plus pyrimethamine-sulphadoxine on gametocytes during and after treatment of acute, uncomplicated malaria in children
  31. The effects of artemether–lumefantrine vs amodiaquine–sulfalene–pyrimethamine on the hepatomegaly associated with Plasmodium falciparum malaria in children
  32. Predictors of the failure of treatment with pyrimethamine–sulfadoxine in children with uncomplicated falciparum malaria
  33. Predictors of the failure of treatment with trimethoprim–sulfamethoxazole in children with uncomplicated, Plasmodium falciparum malaria
  34. Response to chloroquine treatment in children with or without gametocytes during uncomplicated Plasmodium falciparum malaria
  35. Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children
  36. Plasmodium falciparum Malaria in Nigerian Children During High and Low Transmission Seasons: Gametocyte Carriage and Response to Oral Chloroquine
  37. Predictors of the failure of treatment with chloroquine in children with acute, uncomplicated,Plasmodium falciparummalaria, in an area with high and increasing incidences of chloroquine resistance
  38. Effects of antifolates - co-trimoxazole and pyrimethamine-sulfadoxine - on gametocytes in children with acute, symptomatic, uncomplicated, Plasmodium falciparum malaria
  39. Predictors of the failure of treatment with chloroquine plus chlorpheniramine, in children with acute, uncomplicated,Plasmodium falciparummalaria
  40. Comparative effects of pyrimethamine–sulfadoxine, with and without probenecid, onPlasmodium falciparumgametocytes in children with acute, uncomplicated malaria
  41. Risk factors for gametocyte carriage in uncomplicated falciparum malaria in children
  42. Plasmodium falciparumhyperparasitaemia in children
  43. Open randomized study of pyrimethamine-sulphadoxine vs. pyrimethamine-sulphadoxine plus probenecid for the treatment of uncomplicated Plasmodium falciparum malaria in children
  44. Cotrimoxazole in the Treatment of Acute Uncomplicated Falciparum Malaria in Nigerian Children
  45. The effects of chloroquine, amodiaquine and chloroquine plus chlorpheniramine on the disposition kinetics of the hepatomegaly associated with acute, uncomplicated,Plasmodium falciparummalaria in children
  46. Comparative clinical characteristics and responses to oral 4-aminoquinoline therapy of malarious children who did and did not develop 4-aminoquinoline-induced pruritus
  47. Randomized comparison of chloroquine and amodiaquine in the treatment of acute, uncomplicated, Plasmodium falciparum malaria in children
  48. Analgesic activity of Peperomia pellucida aerial parts in mice
  49. Clinical characteristics and disposition kinetics of the hepatomegaly associated with acute, uncomplicated, Plasmodium falciparum malaria in children
  50. Comparison of Artemether and Artemether plus Mefloquine in Children with Malaria and Effects on Viability of Plasmodium falciparum Ex vivo
  51. Comparative Plasmodium falciparum Kinetics during Treatment with Amodiaquine and Chloroquine in Children
  52. Pharmacological Screening of a Methanol Extract from Mormodica charantia in Rodents
  53. Comparative Efficacy and Safety of Two Regimens of Chlorpheniramine plus Chloroquine in Acute Uncomplicated Falciparum Malaria in Children
  54. Patterns of Change in the Electrocardiogram after Halofantrine Treatment of Acute Uncomplicated Falciparum Malaria in Children
  55. Comparative clinical characteristics and response to oral antimalarial therapy of children with and withoutPlasmodium falciparumhyperparasitaemia in an endemic area
  56. Plasmodium falciparum Kinetics during Treatment with Antimalarial Drugs in Children
  57. Comparative efficacy of chloroquine plus chlorpheniramine alone and in a sequential combination with sulfadoxine–pyrimethamine, for the treatment of acute, uncomplicated, falciparum malaria in children